Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California.
Seattle Children's Research Institute, Seattle, Washington.
Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L892-L899. doi: 10.1152/ajplung.00434.2020. Epub 2021 Sep 1.
Down syndrome (DS) is one of the most prevalent chromosomal abnormalities worldwide, affecting 1 in 700 live births. Although multiple organ systems are affected by the chromosomal defects, respiratory failure and lung disease are the leading causes of morbidity and mortality observed in DS. Manifestations of DS in the respiratory system encompass the entire lung starting from the nasopharynx to the trachea/upper airways to the lower airways and alveolar spaces, as well as vascular and lymphatic defects. Most of our knowledge on respiratory illness in persons with DS arises from pediatric studies; however, many of these disorders present early in infancy, supporting developmental mechanisms. In this review, we will focus on the different lung phenotypes in DS, as well as the genetic and molecular pathways that may be contributing to these complications during development.
唐氏综合征(DS)是全球最常见的染色体异常之一,每 700 例活产中就有 1 例受到影响。尽管多个器官系统受到染色体缺陷的影响,但呼吸衰竭和肺部疾病是 DS 患者发病率和死亡率高的主要原因。DS 在呼吸系统中的表现涵盖了从鼻咽部到气管/上呼吸道到下呼吸道和肺泡腔的整个肺部,以及血管和淋巴系统的缺陷。我们对 DS 患者呼吸系统疾病的了解主要来自儿科研究;然而,许多这些疾病在婴儿期早期就出现了,这支持了发育机制。在这篇综述中,我们将重点介绍 DS 中的不同肺部表型,以及可能导致这些发育过程中并发症的遗传和分子途径。